Pleural fibrosis.
Jantz MA, Antony VB.
Clin Chest Med. 2006 Jun;27(2):181-91. doi: 10.1016/j.ccm.2005.12.003.
Update on Novel Targeted Therapy for Pleural Organization and Fibrosis.
Tucker TA, Idell S.
Int J Mol Sci. 2022 Jan 29;23(3):1587. doi: 10.3390/ijms23031587.
Pathogenesis of pleural fibrosis.
Mutsaers SE, Prele CM, Brody AR, Idell S.
Respirology. 2004 Nov;9(4):428-40. doi: 10.1111/j.1440-1843.2004.00633.x.
Splicing factor SRSF6 mediates pleural fibrosis.
Liang LM, Xiong L, Cheng PP, Chen SJ, Feng X, Zhou YY, Niu Q, Wang M, Chen Q, Song LJ, Yu F, He XL, Xiang F, Wang X, Ye H, Ma WL.
JCI Insight. 2021 May 24;6(10):e146197. doi: 10.1172/jci.insight.146197.
DOCK2 Promotes Pleural Fibrosis by Modulating Mesothelial to Mesenchymal Transition.
Qian G, Adeyanju O, Roy S, Sunil C, Jeffers A, Guo X, Ikebe M, Idell S, Tucker TA.
Am J Respir Cell Mol Biol. 2022 Feb;66(2):171-182. doi: 10.1165/rcmb.2021-0175OC.
Causes and management of pleural fibrosis.
Huggins JT, Sahn SA.
Respirology. 2004 Nov;9(4):441-7. doi: 10.1111/j.1440-1843.2004.00630.x.
Pleuroparenchymal fibroelastosis.
Cottin V, Si-Mohamed S, Diesler R, Bonniaud P, Valenzuela C.
Curr Opin Pulm Med. 2022 Sep 1;28(5):432-440. doi: 10.1097/MCP.0000000000000907. Epub 2022 Jul 18.
Crosstalk between pleural mesothelial cell and lung fibroblast contributes to pulmonary fibrosis.
Liu F, Yu F, Lu YZ, Cheng PP, Liang LM, Wang M, Chen SJ, Huang Y, Song LJ, He XL, Xiong L, Xin JB, Ma WL, Ye H.
Biochim Biophys Acta Mol Cell Res. 2020 Nov;1867(11):118806. doi: 10.1016/j.bbamcr.2020.118806. Epub 2020 Jul 31.
Endothelial Cell Protein C Receptor Deficiency Attenuates Streptococcus pneumoniae-induced Pleural Fibrosis.
Keshava S, Magisetty J, Tucker TA, Kujur W, Mulik S, Esmon CT, Idell S, Rao LVM, Pendurthi UR.
Am J Respir Cell Mol Biol. 2021 Apr;64(4):477-491. doi: 10.1165/rcmb.2020-0328OC.
Pathogenesis of pleurisy, pleural fibrosis, and mesothelial proliferation.
Herbert A.
Thorax. 1986 Mar;41(3):176-89. doi: 10.1136/thx.41.3.176.
